Profile of Cabozantinib for the Treatment of Hepatocellular Carcinoma: Patient Selection and Special Considerations

por Debaillon Vesque, Audrey, Decraecker, Marie, Blanc, Jean-Frédéric
Publicado 2020

Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress

por Bayard, Quentin, Meunier, Léa, Peneau, Camille, Renault, Victor, Shinde, Jayendra, Nault, Jean-Charles, Mami, Iadh, Couchy, Gabrielle, Amaddeo, Giuliana, Tubacher, Emmanuel, Bacq, Delphine, Meyer, Vincent, La Bella, Tiziana, Debaillon-Vesque, Audrey, Bioulac-Sage, Paulette, Seror, Olivier, Blanc, Jean-Frédéric, Calderaro, Julien, Deleuze, Jean-François, Imbeaud, Sandrine, Zucman-Rossi, Jessica, Letouzé, Eric
Publicado 2018